Pilot program, first pitched under Biden, will cover GLP-1 drugs such as Ozempic to address chronic obesity in US
The Trump administration is planning a pilot program to cover “miracle” weight loss drugs under the government health insurance systems for low-income people and retirees, Medicaid and Medicare, in a move aimed at tackling the US’s chronic obesity problem.
Such a plan was previously proposed by the Biden administration in its final months before Donald Trump re-entered the White House after winning a second term in office in the 2024 election.
